Symbols / HIMS
HIMS Chart
About
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Spe | Market Cap | 3.61B |
| Enterprise Value | 4.15B | Income | 128.37M | Sales | 2.35B |
| Book/sh | 2.38 | Cash/sh | 2.53 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2442 | IPO | — |
| P/E | 31.02 | Forward P/E | 10.55 | PEG | — |
| P/S | 1.54 | P/B | 6.65 | P/C | — |
| EV/EBITDA | 23.62 | EV/Sales | 1.77 | Quick Ratio | 1.51 |
| Current Ratio | 1.90 | Debt/Eq | 207.16 | LT Debt/Eq | — |
| EPS (ttm) | 0.51 | EPS next Y | 1.50 | EPS Growth | -17.40% |
| Revenue Growth | 28.40% | Earnings | 2026-05-04 | ROA | 5.29% |
| ROE | 25.23% | ROIC | — | Gross Margin | 73.83% |
| Oper. Margin | 2.72% | Profit Margin | 5.47% | Shs Outstand | 219.56M |
| Shs Float | 208.27M | Short Float | 44.12% | Short Ratio | 2.69 |
| Short Interest | — | 52W High | 70.43 | 52W Low | 15.06 |
| Beta | 2.47 | Avg Volume | 20.68M | Volume | 36.32M |
| Target Price | $20.19 | Recom | Hold | Prev Close | $15.46 |
| Price | $15.82 | Change | 2.33% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$20.19
Mean price target
2. Current target
$15.82
Latest analyst target
3. DCF / Fair value
$9.06
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$15.82
Low
$12.50
High
$30.00
Mean
$20.19
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-25 | main | Barclays | Overweight → Overweight | $25 |
| 2026-02-25 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $21 |
| 2026-02-24 | main | Leerink Partners | Market Perform → Market Perform | $18 |
| 2026-02-24 | down | BTIG | Buy → Neutral | — |
| 2026-02-24 | main | Citigroup | Sell → Sell | $13 |
| 2026-02-24 | main | TD Cowen | Hold → Hold | $17 |
| 2026-02-24 | reit | Truist Securities | Hold → Hold | $18 |
| 2026-02-24 | main | Evercore ISI Group | In-Line → In-Line | $24 |
| 2026-02-09 | main | TD Cowen | Hold → Hold | $20 |
| 2026-02-09 | main | Citigroup | Sell → Sell | $17 |
| 2026-02-09 | main | B of A Securities | Underperform → Underperform | $21 |
| 2026-02-02 | main | BTIG | Buy → Buy | $60 |
| 2026-01-12 | init | Evercore ISI Group | — → In-Line | $33 |
| 2025-12-09 | init | Barclays | — → Overweight | $48 |
| 2025-11-04 | main | B of A Securities | Underperform → Underperform | $32 |
| 2025-11-04 | reit | BTIG | Buy → Buy | $85 |
| 2025-10-21 | init | Keybanc | — → Sector Weight | — |
| 2025-09-12 | main | Canaccord Genuity | Buy → Buy | $68 |
| 2025-08-18 | main | Truist Securities | Hold → Hold | $37 |
| 2025-08-05 | reit | Needham | Hold → Hold | — |
- Hims & Hers Health discloses SEC investigation over copycat GLP-1s; stock falls (HIMS:NYSE) - Seeking Alpha ue, 24 Feb 2026 04
- Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results - Hims Investor Relations Mon, 23 Feb 2026 21
- HIMS Earnings: Hims & Hers Health Stock Down after Mixed Q4 Results - TipRanks Mon, 23 Feb 2026 21
- Hims & Hers Stock Drops. Why Earnings Are Underwhelming Investors. - Barron's ue, 24 Feb 2026 15
- Hims & Hers forecasts first-quarter sales below estimates, shares fall - Reuters Mon, 23 Feb 2026 21
- Assessing Hims & Hers Health (HIMS) Valuation After The Recent Share Price Pullback - Yahoo Finance ue, 24 Feb 2026 01
- Hims reports Q4 earnings beat, revenue miss - Sherwood News Mon, 23 Feb 2026 21
- Earnings live: Home Depot stock climbs after earnings beat, Hims & Hers slides, Constellation Energy rises - Yahoo Finance ue, 24 Feb 2026 21
- HIMS vs. AMWL: Which Telehealth Stock Is the Better Investment Now? - Yahoo Finance Wed, 25 Feb 2026 17
- Hims And Hers Balances GLP 1 Scrutiny With Eucalyptus Expansion Plans - Yahoo Finance Wed, 25 Feb 2026 07
- Hims & Hers: The Telehealth Growth Story Younger Investors Can't Afford to Ignore - Yahoo Finance hu, 26 Feb 2026 12
- Hims & Hers Health Fourth-Quarter Sales Rise, Gives Soft First-Quarter Guidance - WSJ Mon, 23 Feb 2026 23
- Hims & Hers: The Telehealth Growth Story Younger Investors Can't Afford to Ignore - The Motley Fool hu, 26 Feb 2026 12
- Hims & Hers shares slip on underwhelming first-quarter guidance - Investing.com Mon, 23 Feb 2026 21
- Hims & Hers in Free Fall: Why Analysts See Nearly 150% Upside - MarketBeat Sat, 21 Feb 2026 15
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 5262 | 26363.0 | — | Conversion of Exercise of derivative security at price 5.01 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-02-03 00:00:00 | D |
| 1 | 5262 | 139108.0 | — | Sale at price 26.44 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-02-03 00:00:00 | D |
| 2 | 9067 | 56836.0 | — | Conversion of Exercise of derivative security at price 5.01 - 11.53 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-01-20 00:00:00 | D |
| 3 | 9067 | 275114.0 | — | Sale at price 30.34 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-01-20 00:00:00 | D |
| 4 | 5986 | 54818.0 | — | Conversion of Exercise of derivative security at price 5.01 - 11.53 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-01-05 00:00:00 | D |
| 5 | 9070 | 306453.0 | — | Sale at price 33.79 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-01-05 00:00:00 | D |
| 6 | 23090 | 824710.0 | — | Sale at price 35.72 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2025-12-22 00:00:00 | D |
| 7 | 10021 | 367871.0 | — | Sale at price 36.71 per share. | CARROLL PATRICK HARRISON | Officer and Director | — | 2025-12-17 00:00:00 | D |
| 8 | 13750 | 504762.0 | — | Sale at price 36.71 per share. | CHI MICHAEL Y | Chief Operating Officer | — | 2025-12-17 00:00:00 | D |
| 9 | 7054 | 258952.0 | — | Sale at price 36.71 per share. | AUTOR DEBORAH M | Officer and Director | — | 2025-12-17 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.21 | 0.21 | 0.00 | 0.03 |
| NormalizedEBITDA | 78.99M | -19.94M | -61.22M | -110.97M |
| TotalUnusualItems | 70.00K | 3.80M | ||
| TotalUnusualItemsExcludingGoodwill | 70.00K | 3.80M | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | 126.04M | -23.55M | -65.68M | -107.66M |
| ReconciledDepreciation | 17.09M | 9.52M | 7.47M | 4.08M |
| ReconciledCostOfRevenue | 303.38M | 157.05M | 118.19M | 67.38M |
| EBITDA | 78.99M | -19.94M | -61.22M | -110.97M |
| EBIT | 61.90M | -29.45M | -68.70M | -115.04M |
| NetInterestIncome | 0.00 | |||
| InterestExpense | 0.00 | |||
| NormalizedIncome | 126.04M | -23.55M | -65.68M | -107.66M |
| NetIncomeFromContinuingAndDiscontinuedOperation | 126.04M | -23.55M | -65.68M | -107.66M |
| TotalExpenses | 1.41B | 901.45M | 595.61M | 386.92M |
| TotalOperatingIncomeAsReported | 61.90M | -29.45M | -68.70M | -115.04M |
| DilutedAverageShares | 236.81M | 209.34M | 204.52M | 186.78M |
| BasicAverageShares | 215.94M | 209.34M | 204.52M | 186.78M |
| DilutedEPS | 0.53 | -0.11 | -0.32 | -0.58 |
| BasicEPS | 0.58 | -0.11 | -0.32 | -0.58 |
| DilutedNIAvailtoComStockholders | 126.04M | -23.55M | -65.68M | -107.66M |
| NetIncomeCommonStockholders | 126.04M | -23.55M | -65.68M | -107.66M |
| NetIncome | 126.04M | -23.55M | -65.68M | -107.66M |
| NetIncomeIncludingNoncontrollingInterests | 126.04M | -23.55M | -65.68M | -107.66M |
| NetIncomeContinuousOperations | 126.04M | -23.55M | -65.68M | -107.66M |
| TaxProvision | -54.33M | 1.98M | -31.00K | -3.14M |
| PretaxIncome | 71.71M | -21.57M | -65.71M | -110.80M |
| OtherIncomeExpense | 9.81M | 7.88M | 2.99M | 4.25M |
| OtherNonOperatingIncomeExpenses | 9.81M | 7.88M | 2.99M | 4.25M |
| GainOnSaleOfSecurity | 70.00K | 3.80M | ||
| NetNonOperatingInterestIncomeExpense | 0.00 | |||
| InterestExpenseNonOperating | 0.00 | |||
| OperatingIncome | 61.90M | -29.45M | -68.70M | -115.04M |
| OperatingExpense | 1.11B | 744.40M | 477.42M | 319.54M |
| OtherOperatingExpenses | 185.80M | 119.86M | 77.40M | 47.59M |
| ResearchAndDevelopment | 78.82M | 48.23M | 29.24M | 22.38M |
| SellingGeneralAndAdministration | 846.61M | 576.32M | 370.78M | 249.56M |
| SellingAndMarketingExpense | 678.84M | 446.44M | 272.59M | 135.90M |
| GeneralAndAdministrativeExpense | 167.77M | 129.88M | 98.19M | 113.66M |
| OtherGandA | 167.77M | 129.88M | 98.19M | 113.66M |
| GrossProfit | 1.17B | 714.95M | 408.72M | 204.49M |
| CostOfRevenue | 303.38M | 157.05M | 118.19M | 67.38M |
| TotalRevenue | 1.48B | 872.00M | 526.92M | 271.88M |
| OperatingRevenue | 1.48B | 872.00M | 526.92M | 271.88M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 220.84M | 213.48M | 208.43M | 204.79M |
| ShareIssued | 220.84M | 213.48M | 208.43M | 204.79M |
| TotalDebt | 11.35M | 9.95M | 5.31M | 5.48M |
| TangibleBookValue | 320.58M | 214.57M | 179.02M | 197.85M |
| InvestedCapital | 476.72M | 344.03M | 311.74M | 334.62M |
| WorkingCapital | 174.46M | 176.59M | 168.65M | 190.68M |
| NetTangibleAssets | 320.58M | 214.57M | 179.02M | 197.85M |
| CapitalLeaseObligations | 11.35M | 9.95M | 5.31M | 5.48M |
| CommonStockEquity | 476.72M | 344.03M | 311.74M | 334.62M |
| TotalCapitalization | 476.72M | 344.03M | 311.74M | 334.62M |
| TotalEquityGrossMinorityInterest | 476.72M | 344.03M | 311.74M | 334.62M |
| StockholdersEquity | 476.72M | 344.03M | 311.74M | 334.62M |
| GainsLossesNotAffectingRetainedEarnings | -324.00K | -124.00K | -277.00K | -137.00K |
| OtherEquityAdjustments | -324.00K | -124.00K | -277.00K | -137.00K |
| RetainedEarnings | -242.14M | -368.18M | -344.63M | -278.95M |
| AdditionalPaidInCapital | 719.15M | 712.31M | 656.63M | 613.69M |
| CapitalStock | 22.00K | 21.00K | 21.00K | 20.00K |
| CommonStock | 22.00K | 21.00K | 21.00K | 20.00K |
| TotalLiabilitiesNetMinorityInterest | 230.82M | 97.16M | 54.60M | 85.97M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 9.46M | 8.69M | 6.66M | 6.75M |
| OtherNonCurrentLiabilities | 22.00K | 3.01M | 2.63M | |
| PreferredSecuritiesOutsideStockEquity | 0.00 | |||
| LongTermDebtAndCapitalLeaseObligation | 9.46M | 8.67M | 3.65M | 4.12M |
| LongTermCapitalLeaseObligation | 9.46M | 8.67M | 3.65M | 4.12M |
| CurrentLiabilities | 221.37M | 88.47M | 47.94M | 79.22M |
| CurrentDeferredLiabilities | 75.28M | 7.73M | 1.47M | 3.19M |
| CurrentDeferredRevenue | 75.28M | 7.73M | 1.47M | 3.19M |
| CurrentDebtAndCapitalLeaseObligation | 1.89M | 1.28M | 1.66M | 1.36M |
| CurrentCapitalLeaseObligation | 1.89M | 1.28M | 1.66M | 1.36M |
| PayablesAndAccruedExpenses | 144.19M | 79.45M | 44.81M | 74.67M |
| CurrentAccruedExpenses | 53.01M | 28.97M | 11.48M | 11.24M |
| Payables | 91.18M | 50.48M | 33.33M | 63.43M |
| OtherPayable | 7.41M | 42.83M | ||
| TotalTaxPayable | 2.01M | 963.00K | 954.00K | |
| AccountsPayable | 91.18M | 43.07M | 32.36M | 19.64M |
| TotalAssets | 707.54M | 441.19M | 366.34M | 420.58M |
| TotalNonCurrentAssets | 311.71M | 176.13M | 149.75M | 150.68M |
| OtherNonCurrentAssets | 1.00M | 947.00K | 889.00K | 8.80M |
| NonCurrentDeferredAssets | 61.60M | 0.00 | ||
| NonCurrentDeferredTaxesAssets | 61.60M | 0.00 | ||
| GoodwillAndOtherIntangibleAssets | 156.14M | 129.46M | 132.72M | 136.77M |
| OtherIntangibleAssets | 43.41M | 18.57M | 21.84M | 25.89M |
| Goodwill | 112.73M | 110.88M | 110.88M | 110.88M |
| NetPPE | 92.96M | 45.73M | 16.14M | 5.11M |
| AccumulatedDepreciation | -24.50M | -12.24M | -6.24M | |
| GrossPPE | 117.46M | 57.98M | 22.38M | 5.11M |
| Leases | 10.93M | 2.26M | 155.00K | |
| OtherProperties | 44.65M | 24.50M | 6.57M | 5.11M |
| MachineryFurnitureEquipment | 61.88M | 31.22M | 15.65M | |
| Properties | 0.00 | 0.00 | 0.00 | |
| CurrentAssets | 395.83M | 265.05M | 216.59M | 269.90M |
| OtherCurrentAssets | 8.90M | 4.20M | 1.78M | 890.00K |
| CurrentDeferredAssets | 0.00 | |||
| PrepaidAssets | 16.17M | 10.66M | 10.39M | 4.61M |
| Inventory | 64.43M | 22.46M | 21.56M | 13.56M |
| FinishedGoods | 35.08M | 15.22M | 16.48M | 10.43M |
| RawMaterials | 29.35M | 7.24M | 5.08M | 3.13M |
| Receivables | 6.08M | 6.75M | 3.23M | 3.58M |
| AccountsReceivable | 6.08M | 6.75M | 3.23M | 3.58M |
| CashCashEquivalentsAndShortTermInvestments | 300.25M | 220.98M | 179.62M | 247.27M |
| OtherShortTermInvestments | 79.67M | 124.32M | 132.85M | 175.49M |
| CashAndCashEquivalents | 220.58M | 96.66M | 46.77M | 71.78M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 198.33M | 46.99M | -33.78M | -39.42M |
| RepurchaseOfCapitalStock | -83.04M | -2.00M | 0.00 | -22.03M |
| RepaymentOfDebt | 0.00 | 0.00 | ||
| IssuanceOfDebt | 0.00 | 0.00 | 1.19M | |
| IssuanceOfCapitalStock | 0.00 | 0.00 | 272.69M | |
| CapitalExpenditure | -52.75M | -26.49M | -7.25M | -5.01M |
| InterestPaidSupplementalData | 0.00 | 0.00 | ||
| IncomeTaxPaidSupplementalData | 7.92M | 1.11M | 636.00K | 338.00K |
| EndCashPosition | 221.44M | 97.52M | 47.63M | 72.64M |
| BeginningCashPosition | 97.52M | 47.63M | 72.64M | 28.35M |
| EffectOfExchangeRateChanges | -270.00K | -11.00K | -53.00K | -73.00K |
| ChangesInCash | 124.19M | 49.90M | -24.96M | 44.36M |
| FinancingCashFlow | -107.84M | -11.47M | -33.13M | 235.04M |
| CashFlowFromContinuingFinancingActivities | -107.84M | -11.47M | -33.13M | 235.04M |
| NetOtherFinancingCharges | -55.69M | -14.10M | -36.55M | -18.85M |
| ProceedsFromStockOptionExercised | 30.89M | 4.62M | 3.42M | 2.04M |
| NetPreferredStockIssuance | 0.00 | 0.00 | ||
| PreferredStockIssuance | 0.00 | 0.00 | ||
| NetCommonStockIssuance | -83.04M | -2.00M | 0.00 | 250.66M |
| CommonStockPayments | -83.04M | -2.00M | 0.00 | -22.03M |
| CommonStockIssuance | 0.00 | 0.00 | 272.69M | |
| NetIssuancePaymentsOfDebt | 0.00 | 0.00 | 1.19M | |
| NetLongTermDebtIssuance | 0.00 | 0.00 | 1.19M | |
| LongTermDebtPayments | 0.00 | 0.00 | ||
| LongTermDebtIssuance | 0.00 | 0.00 | 1.19M | |
| InvestingCashFlow | -19.05M | -12.11M | 34.70M | -156.27M |
| CashFlowFromContinuingInvestingActivities | -19.05M | -12.11M | 34.70M | -156.27M |
| NetInvestmentPurchaseAndSale | 49.10M | 14.39M | 42.41M | -104.79M |
| SaleOfInvestment | 209.66M | 171.62M | 230.10M | 161.84M |
| PurchaseOfInvestment | -160.56M | -157.24M | -187.70M | -266.63M |
| NetBusinessPurchaseAndSale | -15.40M | 0.00 | -459.00K | -46.47M |
| PurchaseOfBusiness | -15.40M | 0.00 | -459.00K | -46.47M |
| NetIntangiblesPurchaseAndSale | -11.10M | -9.27M | -4.53M | -4.17M |
| PurchaseOfIntangibles | -11.10M | -9.27M | -4.53M | -4.17M |
| NetPPEPurchaseAndSale | -41.66M | -17.22M | -2.71M | -832.00K |
| PurchaseOfPPE | -41.66M | -17.22M | -2.71M | -832.00K |
| OperatingCashFlow | 251.08M | 73.48M | -26.53M | -34.41M |
| CashFlowFromContinuingOperatingActivities | 251.08M | 73.48M | -26.53M | -34.41M |
| ChangeInWorkingCapital | 78.62M | 20.82M | -14.20M | 3.46M |
| ChangeInOtherWorkingCapital | 67.55M | 6.26M | -1.72M | 1.41M |
| ChangeInOtherCurrentLiabilities | -2.44M | -1.93M | -1.60M | -1.52M |
| ChangeInOtherCurrentAssets | -56.00K | -58.00K | 17.00K | -58.00K |
| ChangeInPayablesAndAccruedExpense | 64.68M | 23.85M | 3.45M | 10.05M |
| ChangeInAccruedExpense | 23.79M | 16.52M | 909.00K | 197.00K |
| ChangeInPayable | 40.88M | 7.32M | 2.54M | 9.85M |
| ChangeInAccountPayable | 43.71M | 7.32M | 12.72M | 9.85M |
| ChangeInPrepaidAssets | -9.49M | -6.39M | -6.33M | 3.20M |
| ChangeInInventory | -41.61M | -902.00K | -8.00M | -9.63M |
| OtherNonCashItems | 2.90M | 5.88M | 2.37M | -426.00K |
| StockBasedCompensation | 92.32M | 66.08M | 42.82M | 67.21M |
| AssetImpairmentCharge | 114.00K | 429.00K | 1.13M | 0.00 |
| AmortizationOfSecurities | -4.36M | -5.69M | 146.00K | 2.17M |
| DeferredTax | -61.65M | -13.00K | -594.00K | -3.39M |
| DeferredIncomeTax | -61.65M | -13.00K | -594.00K | -3.39M |
| DepreciationAmortizationDepletion | 17.09M | 9.52M | 7.47M | 4.08M |
| DepreciationAndAmortization | 17.09M | 9.52M | 7.47M | 4.08M |
| OperatingGainsLosses | 154.00K | |||
| GainLossOnInvestmentSecurities | 154.00K | |||
| NetIncomeFromContinuingOperations | 126.04M | -23.55M | -65.68M | -107.66M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for HIMS
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|